Journal of Gastrointestinal Surgery

, Volume 12, Issue 11, pp 1900–1906 | Cite as

Gastroesophageal Reflux Disease and Connective Tissue Disorders: Pathophysiology and Implications for Treatment

  • Marco G. Patti
  • Warren J. Gasper
  • Piero M. Fisichella
  • Ian Nipomnick
  • Francesco Palazzo
ssat poster presentation

Abstract

Introduction

It has been postulated that in patients with connective tissue disorders (CTD) and gastroesophageal reflux disease (GERD), esophageal function is generally deteriorated, often with complete absence of peristalsis. This belief has led to the common recommendation of avoiding antireflux surgery for fear of creating or worsening dysphagia.

Methods

We hypothesized that in most patients with CTD and GERD: (a) esophageal function is often preserved; (b) peristalsis is more frequently absent when end-stage lung disease (ESLD) is also present; (c) a tailored surgical approach (partial or total fundoplication) based on the findings of esophageal manometry allows control of reflux symptoms without a high incidence of postoperative dysphagia. Forty-eight patients with CTD were evaluated by esophageal manometry and 24-hour pH monitoring (EFT). Twenty patients (group A) had EFT because of foregut symptoms, and 28 patients with ESLD (group B) had EFT as part of the lung transplant evaluation. Two hundred and eighty-six consecutive patients with GERD by pH monitoring served as a control group (group C). A laparoscopic fundoplication was performed in two group A patients (total), eight group B patients (three patients total, five patients partial) and in all group C patients (total).

Results

Esophageal peristalsis was preserved in all patients with CTD and GERD. In contrast, peristalsis was absent in about half of patients when ESLD was also present. A tailored surgical approach resulted in control of reflux symptoms in all patients. One patient only developed postoperative dysphagia, which resolved with two Savary dilatations.

Conclusion

These data show that esophageal motor function is preserved in most patients with CTD, so that they should be offered antireflux surgery early in the course of their disease to prevent esophageal and respiratory complications. In patients with ESLD in whom peristalsis is absent, a partial rather than a total fundoplication should be performed, as it allows control of reflux symptoms while avoiding postoperative dysphagia.

Keywords

Connective tissue disorders Gastroesophageal reflux disease Esophageal peristalsis Esophageal manometry Ambulatory pH monitoring Laparoscopic fundoplication End-stage lung disease 

References

  1. 1.
    Zamost BJ, Hirschberg J, Ippoliti AF, Furst DE, Clements PJ, Weinstein WM. Esophagitis in scleroderma. Prevalence and risk factors. Gastroenterology 1987;92:421–428.PubMedGoogle Scholar
  2. 2.
    Remy-Jardin M, Remy J, Wallaert B, Bataille D, Hatron PY. Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology 1993;188:499–506.PubMedGoogle Scholar
  3. 3.
    Shoenut JP, Wieler JA, Micflikier AB. The extent and pattern of gastro-oesophageal reflux in patients with scleroderma oesophagus: the effect of low-dose omeprazole. Aliment Pharmacol Ther 1993;7:509–13.PubMedCrossRefGoogle Scholar
  4. 4.
    Tedesco P, Lobo E, Fisichella PM, Way LW, Patti MG. Laparoscopic fundoplication in elderly patients with gastroesophageal reflux disease. Arch Surg 2006;141:289–292. doi:10.1001/archsurg.141.3.289.PubMedCrossRefGoogle Scholar
  5. 5.
    Sweet MP, Herbella FA, Leard L et al. The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation. Ann Surg 2006;244:491–497.PubMedGoogle Scholar
  6. 6.
    Patti MG, Fisichella PM, Perretta S. Preoperative evaluation of patients with gastroesophageal reflux disease. J Laparoendosc Adv Surg Tech A 2001;11:327–331. doi:10.1089/10926420152761833.PubMedCrossRefGoogle Scholar
  7. 7.
    Jamieson JR, Stein HJ, DeMeester TR et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992;87:1102–1111.PubMedGoogle Scholar
  8. 8.
    Patti MG, Robinson T, Galvani C, Gorodner MV, Fisichella PM, Way LW. Total fundoplication is superior to partial fundoplication even when esophageal peristalsis is weak. J Am Coll Surg 2004;198:863–870. doi:10.1016/j.jamcollsurg.2004.01.029.PubMedCrossRefGoogle Scholar
  9. 9.
    Henry MACA, Harbermann MC, Rocha OM. Esophageal motor disturbances in progressive systemic sclerosis. Dis Esophagus 1999;12:51–53. doi:10.1046/j.1442-2050.1999.00005.x.PubMedCrossRefGoogle Scholar
  10. 10.
    Airo' P, Della Casa D, Danieli E, Missale G, Cattaneo R, Cestari R. Oesophageal manometry in early and definite systemic sclerosis. Clin Rheumatol 2005;24:370–376. doi:10.1007/s10067-004-1049-6.CrossRefGoogle Scholar
  11. 11.
    Marie I, Dominique S, Levesque H, Ducrotte P, Denis P, Hellot MF et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 2001;45:346–354. doi:10.1002/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L.PubMedCrossRefGoogle Scholar
  12. 12.
    Johnson DA, Drane WE, Curran J, Cattau EL, Ciarleglio C, Khan A et al. Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration? Arch Intern Med 1989;149:589–593. doi:10.1001/archinte.149.3.589.PubMedCrossRefGoogle Scholar
  13. 13.
    Patti MG, debas HT, Pellegrini CA. Clinical and functional characterization of high gastroesophageal reflux. Am J Surg 1993;165:163–166. doi:10.1016/S0002-9610(05)80421-0.PubMedCrossRefGoogle Scholar
  14. 14.
    Diener U, Patti MG, Molena D, Fsichella PM, Way LW. Esophageal dysmotility and gastroesophageal reflux disease. J Gastrointest Surg 2001;5:260–265. doi:10.1016/S1091-255X(01)80046-9.PubMedCrossRefGoogle Scholar
  15. 15.
    Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterol 1988;94:73–80.Google Scholar
  16. 16.
    Afeltra A, Zennaro D, Garzia P, Gigante A, Vadacca M, Riggiero A et al. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography. Scand J Rheumatol. 2006;35:388–394. doi:10.1080/03009740600844381.PubMedCrossRefGoogle Scholar
  17. 17.
    Bryan C, Knight C, Black CM, Silman AJ. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 1999;42:2660–2665. doi:10.1002/1529-0131(199912)42:12<2660::AID-ANR23>3.0.CO;2-N.PubMedCrossRefGoogle Scholar
  18. 18.
    Hendel L, Hage E, Hendel J, Stentoft P. Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis. Aliment Pharmacol Ther 1992;6:565–577.PubMedGoogle Scholar
  19. 19.
    Janiak P, Thumshirn M, Menne D, Fox M, Halim S, Fried M et al. Clinical trial: the effect of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis—a randomized controlled, cross-over trial. Aliment Pharmacol Ther 2007;26:1259–1265.PubMedGoogle Scholar
  20. 20.
    Tamhankar AP, Peters JH, Portale G, Hsieh CC, Hagen JA, Bremner CG et al. Omeprazole does not reduce gastroesophageal relux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg 2004;8:888–896. doi:10.1016/j.gassur.2004.08.001.CrossRefGoogle Scholar
  21. 21.
    Mianie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006;55:1398–1402. doi:10.1136/gut.2005.087668.CrossRefGoogle Scholar
  22. 22.
    Mainie I, Tutuina R, Agrawal A, Admas D, Castell D. Comibined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-esophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006;93:1483–1487. doi:10.1002/bjs.5493.PubMedCrossRefGoogle Scholar
  23. 23.
    Richards WO, Torquati A, Holzman MD, Khaitan L, Byrne D, Lufti R et al. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective, randomized, double blind clinical trial. Ann Surg 2004;240:691–694. doi:10.1097/01.sla.0000136940.32255.51.CrossRefGoogle Scholar
  24. 24.
    Watson DI, Jamieson GG, Bessell JR, Devitt PG. Laparoscopic fundoplication in patients with an aperistaltic esophagus and gastroesophageal reflux. Dis Esophagus 2006;19:94–98. doi:10.1111/j.1442-2050.2006.00547.x.PubMedCrossRefGoogle Scholar
  25. 25.
    Dantas RO, Meneghelli UG, Oliveira RB, Villanova MG. Esophageal dysfunction does not always worsen in systemic sclerosis. J Clin Gastroenterol 1993;17:281–285. doi:10.1097/00004836-199312000-00003.PubMedCrossRefGoogle Scholar
  26. 26.
    Heider TR, Behrns KE, Koruda MF, Shaheen NF, Lucktong TA, Bradshaw B et al. Fundoplication improves disordered esophageal motility. J Gastrointest Surg 2003;7:159–163. doi:10.1016/S1091-255X(02)00145-2.PubMedCrossRefGoogle Scholar
  27. 27.
    Herbella FAM, Tedesco P, Nipomnick I, Fisichella PM, Patti MG. Effect of partial and total fundoplication on esophageal body motility. Surg Endosc 2007;21:285–288. doi:10.1007/s00464-006-0108-2.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2008

Authors and Affiliations

  • Marco G. Patti
    • 1
  • Warren J. Gasper
    • 2
  • Piero M. Fisichella
    • 3
  • Ian Nipomnick
    • 2
  • Francesco Palazzo
    • 2
  1. 1.Department of SurgeryUniversity of Chicago Pritzker School of MedicineChicagoUSA
  2. 2.Department of SurgeryUniversity of California, San FranciscoSan FranciscoUSA
  3. 3.Department of SurgeryLoyola University Medical CenterMaywoodUSA

Personalised recommendations